Skip to main content
padlock icon - secure page this page is secure

Open Access The Future of Transcatheter Therapy for Mitral Valve Disease

Download Article:
(HTML 77.1 kb)
(PDF 43,718 kb)
The develop percutaneous treatments for mitral regurgitation (MR) have been based on established surgical procedures. Most are based in some way on mitral annuloplasty. Indirect angioplasty utilizing coronary sinus and leaflet repair with the MitraClip device have the most development and clinical application. More recently, after the success of transcatheter aortic valve replacement, transcatheter mitral valve replacement has emerged. A critical unanswered question is what the relative roles of valve repair and valve replacement will be. The largest experience in practice is with MitraClip leaflet repair. The evidence base for the development of these novel therapies includes some data in surgical candidates, and registry studies that have been done predominantly in high risk populations.

22 References.

No Supplementary Data.
No Article Media
No Metrics

Keywords: annuloplasty; mitral regurgitation; percutaneous mitral repair

Document Type: Research Article

Publication date: May 1, 2016

More about this publication?
  • Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Membership Information
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more